Literature DB >> 21147874

Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors.

Claudia Bighin1, Gianluigi Lunardi, Lucia Del Mastro, Paola Marroni, Paola Taveggia, Alessia Levaggi, Sara Giraudi, Paolo Pronzato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21147874      PMCID： PMC3227929          DOI： 10.1634/theoncologist.2010-0102

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  12 in total

1.  Leuprolide acetate plus aromatase inhibition for male breast cancer.

Authors:  Sharon H Giordano; Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

2.  Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma.

Authors:  A V Kaisary; C J Tyrrell; W B Peeling; K Griffiths
Journal:  Br J Urol       Date:  1991-05

3.  The measurement of estrone sulfate in plasma.

Authors:  D L Loriaux; H J Ruder; M B Lipsett
Journal:  Steroids       Date:  1971-10       Impact factor: 2.668

4.  Estrogen suppression in males: metabolic effects.

Authors:  N Mauras; K O O'Brien; K O Klein; V Hayes
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

5.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study.

Authors:  A Gray; H A Feldman; J B McKinlay; C Longcope
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

6.  Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis.

Authors:  C Franz; D Watson; C Longcope
Journal:  Steroids       Date:  1979-11       Impact factor: 2.668

7.  Progressive osteoporosis during androgen deprivation therapy for prostate cancer.

Authors:  H W Daniell; S R Dunn; D W Ferguson; G Lomas; Z Niazi; P T Stratte
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

8.  Aromatase inhibition in male breast cancer patients: biological and clinical implications.

Authors:  J Doyen; A Italiano; R Largillier; J-M Ferrero; X Fontana; A Thyss
Journal:  Ann Oncol       Date:  2009-10-27       Impact factor: 32.976

Review 9.  Hormonal therapy for male breast cancer: A different approach for a different disease.

Authors:  Zeina A Nahleh
Journal:  Cancer Treat Rev       Date:  2006-02-10       Impact factor: 12.111

10.  Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.

Authors:  P E Lønning; D C Johannessen; T Thorsen
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
View more
  4 in total

1.  A replication study of a candidate locus for follicle-stimulating hormone levels and association analysis for semen quality traits in Japanese men.

Authors:  Youichi Sato; Atsushi Tajima; Motoki Katsurayama; Shiari Nozawa; Miki Yoshiike; Eitetsue Koh; Jiro Kanaya; Mikio Namiki; Kiyomi Matsumiya; Akira Tsujimura; Kiyoshi Komatsu; Naoki Itoh; Jiro Eguchi; Issei Imoto; Aiko Yamauchi; Teruaki Iwamoto
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

2.  Male breast cancer - a single center experience.

Authors:  Branislav Bystricky; Filip Kohutek; Andrej Rosik
Journal:  Oncol Lett       Date:  2016-06-30       Impact factor: 2.967

3.  Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis.

Authors:  Luigi Di Lauro; Laura Pizzuti; Maddalena Barba; Domenico Sergi; Isabella Sperduti; Marcella Mottolese; Carla Azzurra Amoreo; Franca Belli; Patrizia Vici; Valerie Speirs; Daniele Santini; Ruggero De Maria; Marcello Maugeri-Saccà
Journal:  J Hematol Oncol       Date:  2015-05-17       Impact factor: 17.388

4.  Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.

Authors:  F Zagouri; T N Sergentanis; V Koutoulidis; C Sparber; G G Steger; P Dubsky; G C Zografos; T Psaltopoulou; M Gnant; M-A Dimopoulos; R Bartsch
Journal:  Br J Cancer       Date:  2013-05-30       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.